UNITED CAPITAL FINANCIAL ADVISORS, LLC
Position in GH — Guardant Health, Inc.
CIK 1463217
IRVING, TX
Position in GH
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$249,949
-$1,137,662 QoQ
Shares Held
1,666
-85.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#428
of 594 holders
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $57,574,576 across 16 Diagnostics & Research names. GH ranks #15 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
48,493 | $24,312,450 | |
| 2 | DHR |
Danaher Corp /De/
|
95,386 | $18,169,125 | |
| 3 | LH |
Labcorp Holdings Inc.
|
8,214 | $2,299,920 | |
| 4 | WAT |
Waters Corp /De/
|
5,993 | $2,247,614 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
3,624 | $1,907,818 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
8,108 | $1,566,627 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
1,003 | $1,281,342 | |
| 8 | NTRA |
Natera, Inc.
|
4,050 | $1,099,372 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249,949 | 1,666 | Shares | Defined | 2026-08-17 | |
| 2021-09-30 | $1,387,611 | 11,100 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,237,801 | 9,967 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,429,872 | 9,367 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $981,034 | 7,612 | Shares | Defined | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||